Papers/PMID:22610853
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.
Phytotherapy research : PTR2013The record
7 findings drawn from this paper, on 1 compound across 7 endpoints, 6 of them null.
What it reported
How to read these marksWhat moved
1 finding
curcumin — decreases triglycerides
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×3“As for the lipid profile parameters, serum triglycerides were significantly reduced following curcumin supplementation (p = 0.009).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
What did not
6 findings
curcumin — no detected effect on total cholesterol (TC)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
curcumin — no detected effect on LDL cholesterol
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×1“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
curcumin — no detected effect on HDL cholesterol
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×4“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
curcumin — no detected effect on C-reactive protein concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
curcumin — no detected effect on body mass
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×1“Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853
curcumin — no detected effect on body mass index
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- 1 g/day for 30 days
- Population
- obese individuals
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.2013PMID:22610853